Artiva Biotherapeutics
ARTV
#8150
Rank
HK$1.62 B
Marketcap
HK$66.80
Share price
-8.24%
Change (1 day)
N/A
Change (1 year)

Revenue for Artiva Biotherapeutics (ARTV)

Revenue in 2024 (TTM): HK$20.31 Million

According to Artiva Biotherapeutics's latest financial reports the company's current revenue (TTM ) is HK$20.24 Million. In 2023 the company made a revenue of HK$0.23 Billion.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Artiva Biotherapeutics from 2023 to 2024

May 2023Sep 2023$50M$0.1B$0.15B$0.2B$0.25Bcompaniesmarketcap.com

Annual revenue

Year Revenue Change
2024 (TTM) HK$20.31 M-91.33%
2023 HK$0.23 B